Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Christine Sareyko Elvander"'
Autor:
Ann-Christin Arfwidsson, Lennart Ahnfelt, Christine Sareyko Elvander, Lars Frison, Åke Sjöstedt, Ulf Eriksson, Sven Björkström, Mats Ögren, Peter Kälebo, Agnetha Folestad, Bengt I. Eriksson
Publikováno v:
Thrombosis Research. 105:371-378
The first clinical studies evaluating the safety and efficacy of melagatran, a novel, direct thrombin inhibitor, given subcutaneously as prophylaxis for venous thromboembolism (VTE) following total hip (THR) or total knee replacement (TKR) are report
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ffe2836c0d3cc1e68dbb895dee106dc5
https://doi.org/10.1016/s0049-3848(02)00038-5
https://doi.org/10.1016/s0049-3848(02)00038-5
Autor:
Bengt I, Eriksson, Mats, Ogren, Ulf G, Eriksson, Peter, Kälebo, Lennart, Ahnfelt, Sven, Björkström, Ake, Sjöstedt, Agnetha, Folestad, Ann-Christin, Arfwidsson, Christine Sareyko, Elvander, Lars, Frison
Publikováno v:
Thrombosis research. 105(5)
The first clinical studies evaluating the safety and efficacy of melagatran, a novel, direct thrombin inhibitor, given subcutaneously as prophylaxis for venous thromboembolism (VTE) following total hip (THR) or total knee replacement (TKR) are report
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a006069982f8c6e736dd455663b14827
https://pubmed.ncbi.nlm.nih.gov/12062537
https://pubmed.ncbi.nlm.nih.gov/12062537